Gillian Corbett

1.2k total citations
11 papers, 194 citations indexed

About

Gillian Corbett is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Gillian Corbett has authored 11 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Gillian Corbett's work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Protein Degradation and Inhibitors (2 papers). Gillian Corbett is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Protein Degradation and Inhibitors (2 papers). Gillian Corbett collaborates with scholars based in New Zealand, Australia and Greece. Gillian Corbett's co-authors include Alan C. Moss, Jamison L. Nourse, Maher K. Gandhi, Kimberley Jones, Philip Darbyshire, G. Stockdill, Piers Yates, A. C. Parker, H. Miles Prince and Hang Quach and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Gillian Corbett

11 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Corbett New Zealand 7 90 86 51 41 37 11 194
Kunihiko Moriya Japan 9 93 1.0× 35 0.4× 124 2.4× 67 1.6× 43 1.2× 24 265
Emily Avitan‐Hersh Israel 10 55 0.6× 47 0.5× 29 0.6× 87 2.1× 12 0.3× 48 298
Sólrún Melkorka Maggadóttir United States 9 69 0.8× 34 0.4× 124 2.4× 55 1.3× 14 0.4× 16 224
Tingyan He China 9 40 0.4× 32 0.4× 119 2.3× 52 1.3× 36 1.0× 28 207
Marina Eskin‐Schwartz Israel 9 46 0.5× 31 0.4× 20 0.4× 81 2.0× 17 0.5× 32 283
Tanja Telieps Germany 6 72 0.8× 34 0.4× 192 3.8× 53 1.3× 62 1.7× 10 306
Deepika Bhatla United States 7 52 0.6× 26 0.3× 41 0.8× 62 1.5× 102 2.8× 9 199
Céline René France 11 39 0.4× 29 0.3× 173 3.4× 67 1.6× 27 0.7× 19 318
Heiko Sic Germany 6 52 0.6× 19 0.2× 169 3.3× 36 0.9× 30 0.8× 6 236
Bahram Mirsaeid Ghazi Iran 8 102 1.1× 63 0.7× 206 4.0× 39 1.0× 26 0.7× 12 276

Countries citing papers authored by Gillian Corbett

Since Specialization
Citations

This map shows the geographic impact of Gillian Corbett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Corbett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Corbett more than expected).

Fields of papers citing papers by Gillian Corbett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Corbett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Corbett. The network helps show where Gillian Corbett may publish in the future.

Co-authorship network of co-authors of Gillian Corbett

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Corbett. A scholar is included among the top collaborators of Gillian Corbett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Corbett. Gillian Corbett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sharman, Jeff P., Miklós Egyed, Wojciech Jurczak, et al.. (2021). Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.. Journal of Clinical Oncology. 39(15_suppl). 7509–7509. 17 indexed citations
2.
Quach, Hang, Gillian Corbett, Peter Browett, et al.. (2017). Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study. British Journal of Haematology. 177(3). 441–448. 15 indexed citations
3.
Corbett, Gillian, et al.. (2016). Barotrauma induced tracheal diverticulum rupture: imaging findings. BMJ Case Reports. 2016. bcr2016217518–bcr2016217518. 2 indexed citations
4.
Corbett, Gillian, et al.. (2016). Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 10(5). 619–625. 94 indexed citations
5.
6.
7.
8.
Jones, Kimberley, Jamison L. Nourse, Gillian Corbett, & Maher K. Gandhi. (2009). Sodium valproate in combination with ganciclovir induces lysis of EBV‐infected lymphoma cells without impairing EBV‐specific T‐cell immunity. International Journal of Laboratory Hematology. 32(1p1). e169–74. 22 indexed citations
9.
Morris, Christopher M., et al.. (1989). HRAS1 and INS genes are relocated but not structurally altered as a result of the t(7;11) (p15;p15) in a clone from a patient with acute myeloid leukaemia (M4). British Journal of Haematology. 71(4). 481–486. 8 indexed citations
10.
Yates, Piers, Gillian Corbett, & G. Stockdill. (1987). Pyoderma gangrenosum and myelodysplasia. Clinical & Laboratory Haematology. 9(4). 425–428. 12 indexed citations
11.
Corbett, Gillian, et al.. (1987). Adult Gaucher disease in association with acute leukaemia. Postgraduate Medical Journal. 63(744). 899–900. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunihiko Moriya Breakdown of academic impact, for papers by Emily Avitan‐Hersh Breakdown of academic impact, for papers by Sólrún Melkorka Maggadóttir Breakdown of academic impact, for papers by Tingyan He Breakdown of academic impact, for papers by Marina Eskin‐Schwartz Breakdown of academic impact, for papers by Tanja Telieps Breakdown of academic impact, for papers by Deepika Bhatla Breakdown of academic impact, for papers by Céline René Breakdown of academic impact, for papers by Heiko Sic Breakdown of academic impact, for papers by Bahram Mirsaeid Ghazi
Rankless by CCL
2026